相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
Ronald Marcus et al.
CEPHALALGIA (2014)
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
Tony W. Ho et al.
NEUROLOGY (2014)
Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity
Serdar Durdagi et al.
BMC PHARMACOLOGY & TOXICOLOGY (2014)
Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
Fabien B. Vincent et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?
C. S. Walker et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Evolution and Emergence of Therapeutic Monoclonal Antibodies What Cardiologists Need to Know
Ian N. Foltz et al.
CIRCULATION (2013)
Expression of recombinant antibodies
Andre Frenzel et al.
FRONTIERS IN IMMUNOLOGY (2013)
In Vivo Quantification of Calcitonin Gene-Related Peptide Receptor Occupancy by Telcagepant in Rhesus Monkey and Human Brain Using the Positron Emission Tomography Tracer [11C]MK-4232
Eric D. Hostetler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Monoclonal antibody therapeutics: history and future
Nicholas A. P. S. Buss et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Gary Bloomgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Mechanisms of Monoclonal Antibody-Drug Interactions
Honghui Zhou et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
David J. Hewitt et al.
CEPHALALGIA (2011)
Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation
Ann C. Raddant et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Application of Quantitative Pharmacology in Development of Therapeutic Monoclonal Antibodies
Mohammad Tabrizi et al.
AAPS JOURNAL (2010)
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
Jakob Moller Hansen et al.
CEPHALALGIA (2010)
Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
Ron J. Keizer et al.
CLINICAL PHARMACOKINETICS (2010)
Neurogenic inflammation: a study of rat trigeminal ganglion
Kim Anker Kristiansen et al.
JOURNAL OF HEADACHE AND PAIN (2010)
Engineering Fully Human Monoclonal Antibodies from Murine Variable Regions
Matthew J. Bernett et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies
Frank R. Brennan et al.
MABS (2010)
The safety and side effects of monoclonal antibodies
Trevor T. Hansel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases
Reinhard Gabathuler
NEUROBIOLOGY OF DISEASE (2010)
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology
Alessandro Capuano et al.
MOLECULAR PAIN (2009)
Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils
Kang Chen et al.
NATURE IMMUNOLOGY (2009)
Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
Rafael Ponce et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells
Jing Li et al.
BRAIN RESEARCH (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
Neuron-glia signaling in trigeminal ganglion: Implications for migraine pathology
Srikanth Thalakoti et al.
HEADACHE (2007)
Preclinical and clinical safety of monoclonal antibodies
Mohammad A. Tabrizi et al.
DRUG DISCOVERY TODAY (2007)
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
Geertje M. Bartelds et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs
Gopi Shankar et al.
NATURE BIOTECHNOLOGY (2007)
Immunogenicity, efficacy and adverse events of adalimumab in RA patients
Niko K. Bender et al.
RHEUMATOLOGY INTERNATIONAL (2007)
The role of mast cells in migraine pathophysiology
TC Theoharides et al.
BRAIN RESEARCH REVIEWS (2005)
Monoclonal versus polyclonal antibodies: Distinguishing characteristics, applications, and information resources
NS Lipman et al.
ILAR JOURNAL (2005)
Pharmacokinetics and concentration-effect relationships of therapeutic monoclonal antibodies and fusion proteins
D Ternant et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Drug therapy: Drug-induced prolongation of the QT interval
DM Roden
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Antibody pharmacokinetics and pharmacodynamics
ED Lobo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Immunogenicity of therapeutic proteins: Clinical implications and future prospects
H Schellekens
CLINICAL THERAPEUTICS (2002)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
The immune system - First of two parts
PJ Delves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
